N, P., LA, C., JJ, P., J, D., T, P., J, d. l. R., . . . EM, O. (2020). Pembrolizumab as Consolidation Strategy in Patients with Multiple Myeloma: Results of the GEM-Pembresid Clinical Trial.
Citación estilo ChicagoN, Puig, et al. Pembrolizumab As Consolidation Strategy in Patients With Multiple Myeloma: Results of the GEM-Pembresid Clinical Trial. 2020.
Cita MLAN, Puig, et al. Pembrolizumab As Consolidation Strategy in Patients With Multiple Myeloma: Results of the GEM-Pembresid Clinical Trial. 2020.
Precaución: Estas citas no son 100% exactas.